Please assess the completion status of the following clinical trial:

Trial Title: Leg Amputation and Continuous Sciatic Nerve Block

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients scheduled for leg amputation following arteritis~* ASA score: 2-3~* Informed consent obtained from the patient~Exclusion Criteria:~* Patients involved in another clinical trial~* Post-infection OR post traumatic leg amputation~* Blood coagulation disorders~* Local anesthetic, morphine, or paracetamol allergy~* Local inflammatory signs~* Pregnant or breastfeeding women~* Patients with protective supervision

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Continuous sciatic nerve bloc : ropivacaine infusion
- 2 (Type: PLACEBO_COMPARATOR): Continuous sciatic nerve bloc : NaCl Infusion

Based on this trial design, predict the completion outcome and termination type (if applicable).